Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Fred, Junghus"'
Autor:
Laetitia Fend, Eric Quemeneur, Monika Semmrich, Jean-Baptiste Marchand, Matilda Rehn, Nathalie Silvestre, Linda Mårtensson, Johann Foloppe, Ingrid Teige, Björn Frendeus, Petra Holmkvist, Carolin Svensson, Christelle Remy, Patricia Kleinpeter, Jules Deforges, Fred Junghus, Kirstie L Cleary, Mimoza Bodén
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 1 (2022)
Externí odkaz:
https://doaj.org/article/715bfd92355a4c01a650b6be33e6abb9
Autor:
Monika Semmrich, Jean-Baptiste Marchand, Laetitia Fend, Matilda Rehn, Christelle Remy, Petra Holmkvist, Nathalie Silvestre, Carolin Svensson, Patricia Kleinpeter, Jules Deforges, Fred Junghus, Kirstie L Cleary, Mimoza Bodén, Linda Mårtensson, Johann Foloppe, Ingrid Teige, Eric Quéméneur, Björn Frendéus
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 1 (2022)
BackgroundImmune checkpoint blockade (ICB) is a clinically proven concept to treat cancer. Still, a majority of patients with cancer including those with poorly immune infiltrated ‘cold’ tumors are resistant to currently available ICB therapies.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::422945ff6754e9a6ad3d2b4f27d8959c
https://jitc.bmj.com/content/10/1/e003488.full
https://jitc.bmj.com/content/10/1/e003488.full
Autor:
Monika, Semmrich, Jean-Baptiste, Marchand, Laetitia, Fend, Matilda, Rehn, Christelle, Remy, Petra, Holmkvist, Nathalie, Silvestre, Carolin, Svensson, Patricia, Kleinpeter, Jules, Deforges, Fred, Junghus, Kirstie L, Cleary, Mimoza, Bodén, Linda, Mårtensson, Johann, Foloppe, Ingrid, Teige, Eric, Quéméneur, Björn, Frendéus
Publikováno v:
Journal for Immunotherapy of Cancer
Background Immune checkpoint blockade (ICB) is a clinically proven concept to treat cancer. Still, a majority of patients with cancer including those with poorly immune infiltrated ‘cold’ tumors are resistant to currently available ICB therapies.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::09bd94ed6325ee24b261cd0627e28c52
https://pubmed.ncbi.nlm.nih.gov/35058324
https://pubmed.ncbi.nlm.nih.gov/35058324
Autor:
Jean-Baptiste Marchand, Monika Semmrich, Christelle Ziller, Matilda Rehn, Laetitia Fend, Petra Holmkvist, Nathalie Silvestre, Carolin Svensson, Kleinpeter Patricia, Jules Deforges, Fred Junghus, Linda Mårtensson, Johann Foloppe, Ingrid Teige, Björn Frendéus, Eric Quéméneur
Publikováno v:
Cancer Research. 82:3567-3567
Background Immune checkpoint blockade (ICB) is a clinically proven concept to treat cancer. Still, a majority of cancer patients including those with poorly immune infiltrated “cold” tumors are resistant to currently available ICB therapies. Onco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b9b43b28ad955ed7dc3b41cd5a960182
https://doi.org/10.1158/1538-7445.am2022-3567
https://doi.org/10.1158/1538-7445.am2022-3567
Autor:
Christelle Remy-Ziller, Fred Junghus, Johann Foloppe, Ingrid Teige, Petra Holmkvist, Patricia Kleinpeter, Carolin Svensson, Björn Frendéus, Matilda Rehn, Monika Semmrich, Jules Deforges, Eric Quéméneur, Jean-Baptiste Marchand, Linda Mårtensson, Nathalie Silvestre, Laetitia Fend
Publikováno v:
Journal for ImmunoTherapy of Cancer. 9:A777-A777
BackgroundImmune checkpoint blockade (ICB) is a clinically proven concept to treat cancer. Still, a majority of cancer patients including those with poorly immune infiltrated “cold” tumors are resistant to currently available ICB therapies. CTLA-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8937a049af40a581fad8e99f5ad0f9a5
https://doi.org/10.1136/jitc-2021-sitc2021.746
https://doi.org/10.1136/jitc-2021-sitc2021.746